儿童重型创伤性脑损伤颅内压监测装置全国性比较:对手术干预与死亡率的影响
该研究基于美国外科医师学会创伤质量改进项目(2017—2021年)数据分析,纳入4,250例接受有创颅内压监测的儿童(小于18岁)重型创伤性脑损伤患者,按监测方式分为脑室外引流组与脑实质监测组,排除同时使用两种装置者。脑室外引流组手术干预率46%低于脑实质监测组56.9%(P<0.001),总体死亡率20%两组无显著差异(P=0.432)。多因素回归显示,脑室外引流与死亡率降低独立相关(校正OR 0.750,P=0.019),与需手术干预减少独立相关(校正OR 0.702,P<0.001)。作者结论认为脑室外引流单用与需手术干预减少30%、死亡率降低25%相关,并指出需进一步评估两种装置的相对获益。
要点
- 儿童重型颅脑损伤仅用脑室外引流者手术干预率46%,低于仅用脑实质监测者的56.9%(P<0.001)。
- 多因素回归中脑室外引流与死亡率降低独立相关(校正OR 0.750,P=0.019)。
- 多因素回归中脑室外引流与需手术干预减少独立相关(校正OR 0.702,P<0.001)。
- 总体死亡率20%,脑室外引流组与脑实质监测组无显著差异(P=0.432)。
- 作者结论:脑室外引流单用与需手术干预减少30%、死亡率降低25%相关,需进一步评估相对获益。
适用人群与场景
- 美国外科医师学会创伤质量改进项目(2017—2021年)中,小于18岁的创伤患者,重型创伤性脑损伤,接受有创颅内压监测,且住院至少24小时。
- 排除同时接受脑室外引流与脑实质监测两种装置的患者。
研究设计与关键结果
- 研究类型为美国外科医师学会创伤质量改进项目(2017—2021年)数据分析,纳入4,250例患儿,中位年龄13岁,67%为男性,中位损伤严重度评分27分。
- 64.6%的患者接受脑实质监测;两组儿童创伤中心认证级别分布不同:脑实质监测组在儿童Level II中心比例更高(15.9% vs 10.6%),脑室外引流组在儿童Level III及以下中心比例更高(50.9% vs 45.2%),P<0.001。
- 总体死亡率20%,脑室外引流组与脑实质监测组无显著差异(P=0.432)。
- 手术干预率:脑室外引流组46% vs 脑实质监测组56.9%(P<0.001),脑室外引流组更低。
- 多因素回归:脑室外引流与死亡率降低独立相关(校正OR 0.750,P=0.019),与需手术干预减少独立相关(校正OR 0.702,P<0.001)。
- 作者结论:脑室外引流单用与需手术干预减少30%、死亡率降低25%相关。
证据类型、等级与局限
- 证据类型:美国外科医师学会创伤质量改进项目(2017—2021年)数据分析;证据等级:治疗/临床管理,Level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,尽管儿童颅内压监测选择缺乏指南,脑室外引流单用与需手术干预减少30%、死亡率降低25%相关。
- 作者指出,需进一步评估脑室外引流与脑实质监测在减少该人群手术干预方面的相对获益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Traumatic brain injury is a leading cause of mortality in pediatric trauma, and intracranial pressure (ICP) monitoring is recommended in severe cases. Current guidelines do not favor one monitoring technique over another, and while combined approaches may offer benefits, individual effect of each technique on outcomes remains unclear. The study aim is to analyze differences in invasive monitors.
METHODS: This is analysis of American College of Surgeons Trauma Quality Improvement Program (2017-2021). We included all pediatric (younger than 18 years) trauma patients with severe traumatic brain injury who received invasive ICP monitoring and were admitted for at least 24 hours. Patients were stratified based on type of ICP monitoring: those with an extraventricular drain (EVD) or an intraparenchymal monitor (IPM). Patients who received both monitoring devices were excluded. Primary outcomes included mortality and need for surgical intervention. Multivariable regression analysis was performed.
RESULTS: A total of 4,250 met our inclusion criteria. The median age was 13 years, with 67% being male. The median Injury Severity Score was 27. Majority of patients (64.6%) underwent IPM placement. Distribution of pediatric trauma center verification differed between groups (IPM had a higher proportion at pediatric Level II centers, 15.9% vs. 10.6%, while EVD had a higher proportion at pediatric Level III/below, 50.9% vs. 45.2%; p < 0.001). Overall rate of mortality was 20% with no significant differences between the two groups ( p = 0.432). However, patients in EVD group had a lower rate of surgical intervention (EVD: 46% vs. IPM: 56.9%, p < 0.001). On multivariable regression analysis, EVD was independently associated with decreased mortality (adjusted odds ratio, 0.750; p = 0.019) and need for surgical intervention (adjusted odds ratio, 0.702; p < 0.001).
CONCLUSION: Despite lack of guidelines on choice of ICP monitoring for pediatric patients, EVD placement alone was associated with 30% reduction in need for surgical intervention and 25% lower mortality. These findings highlight the need to further evaluate relative benefits of EVD versus IPM in reducing surgical interventions in this population. ( J Trauma Acute Care Surg . 2026;100: 754-759. Copyright © 2026 Wolters Kluwer Health, Inc. All rights reserved.).
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level IV.
参考来源
- Stewart C, Al Ma'ani M, Castillo-Diaz F, et al. A nationwide comparison of intracranial pressure monitoring devices in pediatric severe traumatic brain injury: Impact on surgical intervention and mortality. J Trauma Acute Care Surg. 2026. PMID: 41925562. doi:10.1097/TA.0000000000004893
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。